BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11713288)

  • 1. Identification of p53 sequence elements that are required for MDM2-mediated nuclear export.
    Gu J; Nie L; Wiederschain D; Yuan ZM
    Mol Cell Biol; 2001 Dec; 21(24):8533-46. PubMed ID: 11713288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular distribution of p53 and p73 are differentially regulated by MDM2.
    Gu J; Nie L; Kawai H; Yuan ZM
    Cancer Res; 2001 Sep; 61(18):6703-7. PubMed ID: 11559539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal ubiquitination of p53 contributes to nuclear export.
    Lohrum MA; Woods DB; Ludwig RL; Bálint E; Vousden KH
    Mol Cell Biol; 2001 Dec; 21(24):8521-32. PubMed ID: 11713287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding.
    Inoue T; Geyer RK; Howard D; Yu ZK; Maki CG
    J Biol Chem; 2001 Nov; 276(48):45255-60. PubMed ID: 11572869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination.
    Nie L; Sasaki M; Maki CG
    J Biol Chem; 2007 May; 282(19):14616-25. PubMed ID: 17371868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.
    Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A
    J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.
    Nakamura S; Roth JA; Mukhopadhyay T
    Mol Cell Biol; 2000 Dec; 20(24):9391-8. PubMed ID: 11094089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a sequence element from p53 that signals for Mdm2-targeted degradation.
    Gu J; Chen D; Rosenblum J; Rubin RM; Yuan ZM
    Mol Cell Biol; 2000 Feb; 20(4):1243-53. PubMed ID: 10648610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53.
    Carter S; Bischof O; Dejean A; Vousden KH
    Nat Cell Biol; 2007 Apr; 9(4):428-35. PubMed ID: 17369817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MDM2 RING-finger domain is required to promote p53 nuclear export.
    Geyer RK; Yu ZK; Maki CG
    Nat Cell Biol; 2000 Sep; 2(9):569-73. PubMed ID: 10980696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination.
    O'Keefe K; Li H; Zhang Y
    Mol Cell Biol; 2003 Sep; 23(18):6396-405. PubMed ID: 12944468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63.
    Calabrò V; Mansueto G; Parisi T; Vivo M; Calogero RA; La Mantia G
    J Biol Chem; 2002 Jan; 277(4):2674-81. PubMed ID: 11714701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53.
    Xirodimas DP; Stephen CW; Lane DP
    Exp Cell Res; 2001 Oct; 270(1):66-77. PubMed ID: 11597128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
    Li M; Brooks CL; Wu-Baer F; Chen D; Baer R; Gu W
    Science; 2003 Dec; 302(5652):1972-5. PubMed ID: 14671306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 and MDMX can interact differently with ARF and members of the p53 family.
    Wang X; Arooz T; Siu WY; Chiu CH; Lau A; Yamashita K; Poon RY
    FEBS Lett; 2001 Feb; 490(3):202-8. PubMed ID: 11223036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyn tyrosine kinase inhibits nuclear export of the p53 tumor suppressor.
    Ren X; Cao C; Zhu L; Yoshida K; Kharbanda S; Weichselbaum R; Kufe D
    Cancer Biol Ther; 2002; 1(6):703-8. PubMed ID: 12642697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 and MDMX bind and stabilize the p53-related protein p73.
    Ongkeko WM; Wang XQ; Siu WY; Lau AW; Yamashita K; Harris AL; Cox LS; Poon RY
    Curr Biol; 1999 Jul 29-Aug 12; 9(15):829-32. PubMed ID: 10469568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role of p73 on the modulation of p53 level through MDM2.
    Wang XQ; Ongkeko WM; Lau AW; Leung KM; Poon RY
    Cancer Res; 2001 Feb; 61(4):1598-603. PubMed ID: 11245471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination.
    Badciong JC; Haas AL
    J Biol Chem; 2002 Dec; 277(51):49668-75. PubMed ID: 12393902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation.
    Zhang Y; Xiong Y
    Science; 2001 Jun; 292(5523):1910-5. PubMed ID: 11397945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.